JANX 27.20 ▼ -3.82% Live Trading Data - Stocknear

Janux Therapeutics Inc.

NASDAQ: JANX · Real-Time Price · USD
27.20
-1.08 (-3.82%)
At close: Oct 16, 2025, 3:59 PM
26.54
-2.43%
After-hours: Oct 16, 2025, 05:39 PM EDT
-3.82%
Bid 25.28
Market Cap 1.63B
Revenue (ttm) -8.07M
Net Income (ttm) -105.64M
EPS (ttm) -1.81
PE Ratio (ttm) -15.03
Forward PE -8.55
Analyst Buy
Dividends n/a
Ask 29.44
Volume 1,341,240
Avg. Volume (20D) 824,782
Open 28.57
Previous Close 28.28
Day's Range 27.02 - 29.09
52-Week Range 21.73 - 71.71
Beta 2.82
Ex-Dividend Date n/a

About JANX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol JANX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for JANX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Janux Therapeutics Inc. is scheduled to release its earnings on Nov 5, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
10 months ago
+11.64%
Janux Therapeutics shares are trading higher after... Unlock content with Pro Subscription
10 months ago
+48.98%
Janux Therapeutics shares are trading higher after the company announced updated interim clinical data for its JANX007 program in prostate cancer.